Applied therapeutics says cash and cash equivalents and short-term investments totaled $38.9 mln as of december 31, 2019

Applied therapeutics reports fourth quarter and year-end 2019 financial results.applied therapeutics - cash and cash equivalents and short-term investments totaled $38.9 million as of december 31, 2019.applied therapeutics - "on diabetic cardiomyopathy program, remain on track to fully enroll our phase 3 registrational study this year".applied therapeutics- plan to move quickly towards regulatory filing for galactosemia, while preparing for its commercial launch.
APLT Ratings Summary
APLT Quant Ranking